Today: 5 March 2026
Browse Category

Stock Market 30 October 2025

Coinbase Stock Soars in Crypto “Uptober” Rally – Will It Hit $500?

Coinbase Stock Soars in Crypto “Uptober” Rally – Will It Hit $500?

Coinbase stock surged above $380 in early October, up 45% year-to-date, as Bitcoin hit a record near $125,000 and U.S. Bitcoin ETFs saw record inflows. Coinbase reported Q3 revenue of $1.9 billion, up 58% from a year ago, with net income of $433 million, beating estimates. Shares jumped 3% after earnings. U.S. regulators dropped a lawsuit against Coinbase, and Congress passed crypto-friendly bills.
Roku Stock Rockets on Surprise Profit – What Investors Need to Know

Roku Stock Rockets on Surprise Profit – What Investors Need to Know

Roku reported Q3 revenue of $1.21 billion, up 14% year-over-year, and posted its first quarterly profit since 2021 at $24.8 million. Shares closed at $100.03 on Oct 30, up 1.4% for the day and about 40% on the week, but fell 8% after-hours as device sales dropped 5%. Roku raised its Q4 revenue outlook to about $1.35 billion and authorized a $50 million stock buyback. Privacy lawsuits were filed in Michigan and Florida.
Bitcoin Boom & Bust: Strategy Inc (MSTR) Stock Soars, Sinks with Crypto’s Wild Ride

Bitcoin Slump Sends MicroStrategy Stock Tumbling – Can Crypto King Bounce Back?

MicroStrategy (NASDAQ: MSTR) closed at $257.80 on Oct. 30, down 6.4% for the day and nearly 14% for the week as bitcoin prices slid. The company reported Q3 net income of $2.8 billion on $128.7 million revenue, driven by unrealized bitcoin gains. MicroStrategy holds about 640,000 bitcoin, acquired at a $47.4 billion cost. Shares are down 30% from July highs but remain up sharply year-over-year.
Amazon’s Stock Skyrockets: Q3 Beat, Cloud and AI Boom Fuel Rally

Amazon’s Stock Skyrockets: Q3 Beat, Cloud and AI Boom Fuel Rally

Amazon shares jumped about 10% in after-hours trading Oct. 30 after reporting Q3 revenue of $180.2 billion, beating estimates, and EPS of $1.95. AWS revenue rose 20% to $33 billion. The company agreed to a $2.5 billion FTC settlement in September and plans to cut around 14,000 corporate jobs. Amazon is hiring 250,000 seasonal workers for the holidays.
Cloudflare (NET) Stock Soars on Q3 Earnings Beat and AI-Security Partnerships – Analysts Predict Further Gains

Cloudflare (NET) Stock Soars on Q3 Earnings Beat and AI-Security Partnerships – Analysts Predict Further Gains

Cloudflare (NYSE: NET) closed at $222.94 on Oct 30, down nearly 2% after hitting $226 intraday, then briefly touched a record $230 in after-hours trading post-earnings. Q3 revenue rose 31% to $562 million, beating estimates; non-GAAP net income reached $102.6 million. The stock is up nearly 100% year-to-date. Wall Street price targets range widely, with an average near $198.
Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix Stock Splits & Soars: Bulls Eye $1,500 After 70% Rally

Netflix closed at $1,089 on Oct. 30, then jumped to about $1,120 in after-hours trading after announcing a 10-for-1 stock split. Shareholders of record Nov. 10 will receive extra shares, with split-adjusted trading starting Nov. 17. The stock is up about 70% year-to-date, fueled by strong subscriber growth and a Q3 revenue rise of 17% to $11.51 billion. Netflix now reports 302 million paid subscribers worldwide.
30 October 2025
Apple’s July 2025 Bombshells: Foldable iPhone, AI Secrets, Encryption Showdown & More

Apple Stock Soars to Record Highs on iPhone 17 ‘Supercycle’ – Can It Hit $300?

Apple closed at about $271.40 on Oct. 30, up 0.6%, after trading between $268.50 and $274.13, near its all-time high. The company’s market value briefly topped $4 trillion this week. Fiscal Q4 revenue hit $102.5 billion, up 8% year-over-year, with record iPhone and Services sales. Trading volume was around 50 million shares, in line with typical levels.
Boqii (NASDAQ: BQ) Stock Explodes 462% on October 30: The Chinese Pet E-Commerce Craze Fueling the Surge

Boqii (NASDAQ: BQ) Stock Explodes 462% on October 30: The Chinese Pet E-Commerce Craze Fueling the Surge

Boqii Holding shares closed at $44.61 on Oct. 30, 2025, up 462% from the prior day, with intraday highs at $55.41 and trading volume near 1.86 million shares. The surge followed news of Yoken’s partnerships with luxury hotels, though Boqii said no undisclosed material news drove the move. Market cap reached $142 million, far above analysts’ $2.50 target. Boqii posted a 2024 net loss of CNY 54.97 million.
30 October 2025
Viavi Stock Skyrockets on Blowout Earnings, AI Data-Center Boom

Viavi Stock Skyrockets on Blowout Earnings, AI Data-Center Boom

Viavi shares jumped 21% to $16.92 on Oct. 30, hitting a multi-year high with trading volume over 10.7 million. Fiscal Q1 revenue rose 25.6% to $299.1 million, beating estimates; non-GAAP EPS reached $0.15. Management guided Q2 revenue to $360–370 million, well above analyst forecasts. The company closed a $425 million acquisition of Spirent’s Ethernet and network-security testing business on Oct. 16.
Reddit RDDT Stock Rockets 200% in 2025 After AI Ad Boom, TikTok Sell-Off and Analyst Upgrades

Reddit Stock Rockets: AI Deals, Earnings Beat and What’s Next for RDDT

Reddit shares fell 5.7% to about $199 intraday Oct. 30, ahead of Q3 earnings. The stock is up 90% from a year ago, but down 14% in the past month after hitting a $282.81 high in September. Analysts expect Q3 revenue near $539 million and EPS of $0.52. Reddit recently sued Perplexity AI for alleged data theft and expanded AI features on its platform.
Moderna Stock Soars on Buyout Buzz – Can New Vaccines Fuel a Comeback?

Moderna Stock Soars on Buyout Buzz – Can New Vaccines Fuel a Comeback?

Moderna shares surged 12% to near $27.50 on Oct. 30, 2025, after reports of takeover talks with a large drugmaker. The rally follows a STAT News report on possible deals, but Moderna declined comment. Despite gains, the stock remains down about 37% year-to-date. Recent FDA approvals include updated COVID and RSV vaccines, but falling COVID demand has cut 2025 revenue and forced cost reductions.
Critical Metals (CRML) Stock Skyrockets on Rare-Earth Boom – What’s Next?

Critical Metals (CRML) Stock Skyrockets on Rare-Earth Boom – What’s Next?

Critical Metals Corp (NASDAQ: CRML) jumped 16.8% to $13.54 on Oct. 30, rebounding from mid-October lows after reports the U.S. may take an 8% stake to secure Greenland’s Tanbreez rare-earth project. Shares had surged to $21.45 before plunging over 65% on profit-taking and trade news. CRML also closed a $35M PIPE and signed 10-year supply deals. Analysts remain cautious, citing high volatility and speculative valuation.
30 October 2025
Navan’s $6.5B IPO Set for Takeoff – TravelTech Unicorn Aims High, But Will It Deliver?

Navan’s IPO Flop? TravelTech Stock Sinks 12% on Nasdaq Debut

Navan priced its IPO at $25 per share on October 30, 2025, raising about $923 million and valuing the company near $6.2 billion. Shares opened at $22, dropping roughly 12% below the IPO price and trading near $21.14 by midday. The company remains unprofitable, reporting a $38.6 million net loss last quarter. Proceeds will be used to pay down $657 million in debt.
30 October 2025
Vivakor (VIVK) Stock Skyrockets on Oil Deal and Trading Debut – Will the Rally Last?

Vivakor (VIVK) Stock Skyrockets on Oil Deal and Trading Debut – Will the Rally Last?

Vivakor shares surged nearly 20% to $0.32 intraday on October 30, 2025, after announcing a $24 million Permian Basin crude oil deal and securing a $40 million credit facility. The Dallas firm also raised $3.5 million in new equity and saw its lender convert $1.45 million of debt into shares, diluting existing holders. VIVK trades below Nasdaq’s $1 minimum and posted a $22 million loss in 2024.
Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health shares jumped 13% to record highs near $185 after fiscal Q1 2026 results beat estimates, with adjusted EPS at $2.55 and revenue at $64.0 billion. The company raised its full-year outlook and announced a $375 million buyback. All five segments grew profits, marking an eighth straight earnings beat. Cardinal plans to close the Solaris Health acquisition by early November.
Apellis’ $458M Shocker: FDA Win, Analyst Buzz & 20% Stock Whiplash

Apellis’ $458M Shocker: FDA Win, Analyst Buzz & 20% Stock Whiplash

Apellis Pharmaceuticals reported Q3 2025 revenue of $458.6 million and a $215.7 million net profit, but its stock fell about 21% after management warned of future losses. Syfovre sales in the U.S. were flat at $150.9 million, with modest injection growth and ongoing debate over its benefits. Empaveli gained FDA approval for rare kidney diseases in July. Analyst ratings and price targets remain divided.
30 October 2025
Go toTop